Ultragenyx Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	-	173.73	213.58	132.94	307.58	713.53	Upgrade
Short-Term Investments	-	436.3	363.63	614.82	432.61	488.01	Upgrade
Cash & Short-Term Investments	494.44	610.03	577.21	747.76	740.2	1,202	Upgrade
Cash Growth	-35.27%	5.68%	-22.81%	1.02%	-38.40%	59.09%	Upgrade
Accounts Receivable	-	121.8	73.39	40.45	28.43	23.09	Upgrade
Other Receivables	-	1.8	1.1	6.4	16	9.6	Upgrade
Receivables	-	123.6	74.49	46.85	44.43	32.69	Upgrade
Inventory	-	45.01	33.97	26.77	16.23	13.05	Upgrade
Prepaid Expenses	-	31.68	44.51	-	55.75	37.18	Upgrade
Restricted Cash	-	6.81	2.01	0.86	-	10.85	Upgrade
Other Current Assets	-	-	-	61.66	-	-	Upgrade
Total Current Assets	-	817.12	732.18	883.9	856.6	1,295	Upgrade
Property, Plant & Equipment	-	291.43	314.47	285.73	176.18	114.04	Upgrade
Long-Term Investments	-	135	199.9	148.97	293.86	165.88	Upgrade
Goodwill	-	44.41	44.41	44.41	44.41	44.41	Upgrade
Other Intangible Assets	-	178.31	166.27	160.11	130.79	131.11	Upgrade
Other Long-Term Assets	-	37.18	33.79	22.34	20.56	6.71	Upgrade
Total Assets	-	1,503	1,491	1,545	1,522	1,760	Upgrade
Accounts Payable	-	38.76	42.11	43.27	17.14	12.92	Upgrade
Accrued Expenses	-	240.97	196.49	204.68	145.56	108.49	Upgrade
Current Portion of Long-Term Debt	-	49.85	29.24	-	-	-	Upgrade
Current Portion of Leases	-	10.3	12.6	11.78	11.07	8.98	Upgrade
Current Unearned Revenue	-	-	-	1.48	7.61	59.22	Upgrade
Other Current Liabilities	-	4.28	-	-	-	-	Upgrade
Total Current Liabilities	-	344.15	280.44	261.21	181.37	189.61	Upgrade
Long-Term Debt	-	819.82	862.33	875.44	351.79	335.67	Upgrade
Long-Term Leases	-	30.04	30.57	19.81	30.9	39.25	Upgrade
Long-Term Unearned Revenue	-	-	-	-	1.47	7.35	Upgrade
Long-Term Deferred Tax Liabilities	-	30.06	30.06	31.67	33.31	33.31	Upgrade
Other Long-Term Liabilities	-	17.08	12.21	4.82	1.01	-	Upgrade
Total Liabilities	-	1,241	1,216	1,193	599.84	605.18	Upgrade
Common Stock	-	0.09	0.08	0.07	0.07	0.07	Upgrade
Additional Paid-In Capital	-	4,213	3,662	3,140	2,997	2,773	Upgrade
Retained Earnings	-	-3,957	-3,388	-2,781	-2,074	-1,620	Upgrade
Treasury Stock	-	-3.59	-0.43	-	-	-	Upgrade
Comprehensive Income & Other	-	2.95	1.08	-6.57	-1.4	0.69	Upgrade
Total Common Equity	144.25	255.3	275.41	352.49	922.56	1,154	Upgrade
Minority Interest	-	7	-	-	-	-	Upgrade
Shareholders' Equity	151.25	262.3	275.41	352.49	922.56	1,154	Upgrade
Total Liabilities & Equity	-	1,503	1,491	1,545	1,522	1,760	Upgrade
Total Debt	889.7	910.01	934.74	907.03	393.76	383.89	Upgrade
Net Cash (Debt)	-326.69	-164.98	-157.63	-10.3	605.37	828.15	Upgrade
Net Cash Growth	-	-	-	-	-26.90%	102.96%	Upgrade
Net Cash Per Share	-3.38	-1.82	-2.14	-0.15	8.93	13.61	Upgrade
Filing Date Shares Outstanding	98.46	92.5	82.34	70.22	69.38	66.95	Upgrade
Total Common Shares Outstanding	98.46	92.48	82.32	70.2	69.34	66.82	Upgrade
Working Capital	-	472.97	451.75	622.69	675.24	1,106	Upgrade
Book Value Per Share	1.54	2.76	3.35	5.02	13.30	17.28	Upgrade
Tangible Book Value	-76.68	32.58	64.74	147.98	747.37	978.86	Upgrade
Tangible Book Value Per Share	-0.82	0.35	0.79	2.11	10.78	14.65	Upgrade
Land	-	16.62	16.62	16.62	15.49	11.72	Upgrade
Buildings	-	181.58	181.36	2.8	-	-	Upgrade
Machinery	-	120.41	116.26	70.28	54.31	41.63	Upgrade
Construction In Progress	-	-	-	189.45	76.85	17.65	Upgrade
Leasehold Improvements	-	58.02	58.68	43.94	44.08	39.36	Upgrade

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.